piracetam and Granuloma studies

piracetam and Granuloma

piracetam has been researched along with Granuloma in 2 studies

Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.

Granuloma: A relatively small nodular inflammatory lesion containing grouped mononuclear phagocytes, caused by infectious and noninfectious agents.

Research Excerpts

Excerpt	Relevance	Reference
"The effect of piracetam has been studied in experimental models of the inflammatory process--the models of rat's paw oedema and intraperitoneal formalin ascites for the exudative phase and the cotton pellet model for the proliferative phase."	7.67	Effect of piracetam in models of experimental inflammation. ( Dushkova, R; Nikolova, M; Petrova, L, 1984)
"The effect of piracetam has been studied in experimental models of the inflammatory process--the models of rat's paw oedema and intraperitoneal formalin ascites for the exudative phase and the cotton pellet model for the proliferative phase."	3.67	Effect of piracetam in models of experimental inflammation. ( Dushkova, R; Nikolova, M; Petrova, L, 1984)

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (50.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Timeframe

Studies, this research(%)

All Research%

pre-1990

1 (50.00)

18.7374

1990's

0 (0.00)

18.2507

2000's

0 (0.00)

29.6817

2010's

1 (50.00)

24.3611

2020's

0 (0.00)

2.80

Authors

Authors	Studies
Ooi, WW	1
Wijemanne, S	1
Thomas, CB	1
Quezado, M	1
Brown, CR	1
Nash, TE	1
Nikolova, M	1
Petrova, L	1
Dushkova, R	1

Studies

Ooi, WW

Wijemanne, S

Thomas, CB

Quezado, M

Brown, CR

Nash, TE

Nikolova, M

Petrova, L

Dushkova, R

Clinical Trials (1)

Trial Overview

Trial	Phase	Enrollment	Study Type	Start Date	Status
Clinical, Laboratory and Imaging Features, Treatment Trends and Long Term Outcomes in Patients With Parenchymal and Extraparenchymal Neurocysticercosis-A Registry Based Study[NCT04706819]		1,000 participants (Anticipated)	Observational [Patient Registry]	2021-01-15	Not yet recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial

Phase

Enrollment

Study Type

Start Date

Status

Clinical, Laboratory and Imaging Features, Treatment Trends and Long Term Outcomes in Patients With Parenchymal and Extraparenchymal Neurocysticercosis-A Registry Based Study[NCT04706819]

1,000 participants (Anticipated)

Observational [Patient Registry]

2021-01-15

Not yet recruiting

[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

2 other studies available for piracetam and Granuloma

Article	Year
Short report: A calcified Taenia solium granuloma associated with recurrent perilesional edema causing refractory seizures: histopathological features. The American journal of tropical medicine and hygiene, 2011, Volume: 85, Issue:3 Topics: Albendazole; Animals; Anthelmintics; Anticonvulsants; Calcinosis; Edema; Granuloma; Humans; Levetira	2011
Effect of piracetam in models of experimental inflammation. International journal of tissue reactions, 1984, Volume: 6, Issue:1 Topics: Animals; Anti-Inflammatory Agents; Ascites; Cell Membrane Permeability; Dose-Response Relationship,	1984

Article

Year

Short report: A calcified Taenia solium granuloma associated with recurrent perilesional edema causing refractory seizures: histopathological features.

The American journal of tropical medicine and hygiene, 2011, Volume: 85, Issue:3

Topics: Albendazole; Animals; Anthelmintics; Anticonvulsants; Calcinosis; Edema; Granuloma; Humans; Levetira

2011

Effect of piracetam in models of experimental inflammation.

International journal of tissue reactions, 1984, Volume: 6, Issue:1

Topics: Animals; Anti-Inflammatory Agents; Ascites; Cell Membrane Permeability; Dose-Response Relationship,

1984